Local demand, competition among pharmacies, and regional regulations can lead to different prices for custom formulations
This triple mechanism is intended to reduce appetite, improve glucose regulation, and increase energy expenditure
Investigators shared new data on retatrutide, an investigational, once-weekly injectable glucose-dependent insulinotropic polypeptide (GIP)/glucagon-like peptide-1 (GLP-1)/glucagon (GCG) receptor agonist, and its effects on obesity, type 2 diabetes, and nonalcoholic steatohepatitis (NASH)
(3) insufficient sample size in some subgroups (e.g., 54 cases in the 360 days
51-OR: A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose-finding Study of BI 456906 in people with overweight/obesity
However, this difference was not observed in our study